These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3936359)

  • 21. Spontaneously acquired factor VIII inhibitor in a 7-year-old girl.
    Nakashima K; Miyahara T; Fujii S; Kaku K; Matsumoto N; Kaneko T
    Acta Haematol; 1982; 68(1):58-62. PubMed ID: 6812357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of animal AHG concentrates (factor VIII) in the treatment of life-threatening hemorrhage in patients with factor VIII antibodies.
    Rubin R; Niemetz J; Estren S
    Ann N Y Acad Sci; 1975 Jan; 240():362-9. PubMed ID: 1053881
    [No Abstract]   [Full Text] [Related]  

  • 23. Cytotoxic suppression of acquired factor VIII:C inhibitors.
    Green D
    Am J Med; 1991 Nov; 91(5A):14S-19S. PubMed ID: 1746590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy.
    Field JJ; Fenske TS; Blinder MA
    Haemophilia; 2007 Jan; 13(1):46-50. PubMed ID: 17212724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The treatment of patients having spontaneously occurring antibodies to antihaemophilic factor (factor VIII).
    Rizza CR; Edgcumbe JO; Pitney WR; Child JA
    Thromb Diath Haemorrh; 1972 Aug; 28(1):120-8. PubMed ID: 5074988
    [No Abstract]   [Full Text] [Related]  

  • 26. Successful management of a patient with an acquired factor VIII inhibitor.
    Sultan Y; Maisonneuve P; Bismuth A; Steg A
    Transfusion; 1983; 23(1):62-4. PubMed ID: 6402833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hereditary hemorrhagic telangiectasia and factor VIII inhibitor.
    Sudarshan A; Natelson EA; Gordon C
    South Med J; 1985 May; 78(5):623-4. PubMed ID: 3922057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclosporine treatment of acquired hemophilia due to factor VIII antibodies.
    Petrovic M; Derom E; Baele G
    Haematologica; 2000 Aug; 85(8):895-6. PubMed ID: 10942956
    [No Abstract]   [Full Text] [Related]  

  • 29. Successful treatment of a patient with idiopathic factor VIII inhibitor with double filtration plasmapheresis and steroid administration.
    Yamazaki M; Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Nakamura S; Naito T; Ohta H
    Blood Coagul Fibrinolysis; 1993 Jun; 4(3):491-5. PubMed ID: 8329575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Spontaneous ecchymosis disclosing acquired factor VIII inhibitor].
    Bayrou O; Deschamps A; Laurian C; Braunstein C; Leynadier F
    Ann Dermatol Venereol; 1993; 120(8):546-8. PubMed ID: 8304713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acquired factor VIII inhibitor.
    Simpson WG; Neefe J; Zang J; Drosick R; Kearns R
    J Ky Med Assoc; 1991 Nov; 89(11):555-7. PubMed ID: 1748831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of life-threatening hemorrhage due to acquired factor VIII inhibitor.
    Pintado T; Taswell HF; Bowie EJ
    Blood; 1975 Oct; 46(4):535-41. PubMed ID: 1080677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Coagulopathy with autoantibodies to blood-clotting factors: overview and laboratory diagnosis].
    Arai M
    Rinsho Byori; 2004 Feb; 52(2):178-81. PubMed ID: 15027324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunosuppressive treatment of a spontaneous inhibitor hemophilia A using cyclophosphamide, vincristine and prednisone following prior Factor VIII stimulation].
    Dürig J; de Wit M; Fiedler W; Marx G; Hossfeld DK
    Schweiz Med Wochenschr; 1996 Nov; 126(47):2026-31. PubMed ID: 8984611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Recombinant factor VIII-CVP therapy for acquired factor VIII inhibitors].
    Mori N; Toyokawa K; Teramura M; Masuda M; Motoji T
    Rinsho Ketsueki; 2007 Jul; 48(7):581-5. PubMed ID: 17695309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current treatment of patients with inhibitors to factor VIII.
    Hilgartner MW
    Haematologia (Budap); 1986; 19(1):21-32. PubMed ID: 3087840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acquired factor VIII inhibitors in non-haemophilic patients: clinical experience of 15 cases.
    Huang YW; Saidi P; Philipp C
    Haemophilia; 2004 Nov; 10(6):713-21. PubMed ID: 15569166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concurrent acquired inhibitors to factor VIII and IX, a laboratory artifact: a case report.
    Doma SA; Hillarp A; Pajič T; Andoljšek D; Černelč P; Preldžnik Zupan I
    Biochem Med (Zagreb); 2016; 26(2):279-84. PubMed ID: 27346976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor.
    Lian EC; Larcada AF; Chiu AY
    Ann Intern Med; 1989 May; 110(10):774-8. PubMed ID: 2496636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acquired hemophilia.
    Bouvry P; Recloux P
    Haematologica; 1994; 79(6):550-6. PubMed ID: 7896216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.